Dissolved and financials
CVR: 38757504
DKK 99,127
Revenue
Net result: DKK -68,343,758
No owners listed
CVR · view owners
No current management
CVR · view management
Dissolved
Ceased 30 October 2025
CVR · view overview
No headcount reported
Director role ended: Jakob Mosegaard Larsen
CVR · 30/10/2025
View the full event history
Forward Pharma Operations ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 30 October 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2024, the company reported revenue of DKK 99,127 and a net result of DKK -68,343,758 compared with DKK 1,043,207 the year before. Equity in the 2024 report amounted to DKK 280,041,147.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202401/01/2024 – 31/12/2024 | 99K | -68.3M | 349.4M | 280M | - | |
| 202301/01/2023 – 31/12/2023 | 547K | 1M | 302.1M | 279.1M | - | |
| 202201/01/2022 – 31/12/2022 | 724K | -27M | 305.1M | 278.1M | - | |
| 202101/01/2021 – 31/12/2021 | 622K | -9.5M | 327.1M | 305.1M | - | |
| 202001/01/2020 – 31/12/2020 | 351K | -10.1M | 337.2M | 314.6M | - | |
| 201901/01/2019 – 31/12/2019 | 327K | -7.5M | 346.7M | 324.7M | - | |
| 201801/01/2018 – 31/12/2018 | 105K | -15.8M | 364.4M | 332.2M | - |
Compared to 1.037 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. Forward Pharma Operations ApS is registered in the Danish CVR register with the status Dissolved and ceased on 30 October 2025.
The CVR number of Forward Pharma Operations ApS is 38757504.
In 2024, Forward Pharma Operations ApS reported revenue of DKK 99,127.
Forward Pharma Operations ApS was founded on 30 June 2017.
Forward Pharma Operations ApS was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
Forward Pharma Operations ApS was located at Strandvejen 125, 2900 Hellerup.
As of October 30, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Forward Pharma Operations ApS.
As of October 30, 2025, Jakob Mosegaard Larsen has stepped down as liquidator of Forward Pharma Operations ApS.
On October 30, 2025, Forward Pharma Operations ApS exited liquidation.
Forward Pharma Operations ApS was dissolved on October 30, 2025.
Forward Pharma Operations ApS has published its annual report for 2024. Revenue came to DKK 99,127, and the net result was DKK -68,343,758.
As of February 26, 2025, Jakob Mosegaard Larsen is registered as liquidator of Forward Pharma Operations ApS.
As of February 26, 2025, Claus Bo Søndergaard Svendsen has stepped down as adm. dir. of Forward Pharma Operations ApS.
On February 26, 2025, Forward Pharma Operations ApS entered liquidation.
Forward Pharma Operations ApS has published its annual report for 2023. Revenue came to DKK 546,952, and the net result was DKK 1,043,207.
Forward Pharma Operations ApS has published its annual report for 2022. Revenue came to DKK 724,020, and the net result was DKK -27,022,415.
As of June 8, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Forward Pharma Operations ApS.
As of June 8, 2023, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Forward Pharma Operations ApS.
Forward Pharma Operations ApS has published its annual report for 2021. Revenue came to DKK 621,559, and the net result was DKK -9,486,972.
Forward Pharma Operations ApS has published its annual report for 2020. Revenue came to DKK 351,024, and the net result was DKK -10,108,937.
Forward Pharma Operations ApS has published its annual report for 2019. Revenue came to DKK 326,709, and the net result was DKK -7,546,712.
Forward Pharma Operations ApS has published its annual report for 2018. Revenue came to DKK 105,339, and the net result was DKK -15,791,179.
Forward Pharma Operations ApS has published its interim report for the period June 30, 2017 to December 31, 2017.
As of June 30, 2017, EY Godkendt Revisionspartnerselskab has been appointed auditor of Forward Pharma Operations ApS.
As of June 30, 2017, Claus Bo Søndergaard Svendsen is registered as adm. dir. of Forward Pharma Operations ApS.
Forward Pharma Operations ApS was founded on June 30, 2017.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 41366044
CVR 32971024
CVR 27701396
CVR 43932489
CVR 33992890
